Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015


Search Results for 'Biologics, Proteins, Vaccines'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 29, 2015
Trexler and Su to lead commercial and medical strategy Read More »
Published May 29, 2015
Will utilize NanoString’s nCounter Analysis to optimize gene expression signatures Read More »
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 22, 2015
To provide aseptic and low bioburden clean room dispensing of bulk materials Read More »
Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 19, 2015
Company continues to support its growing biologics portfolio Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 12, 2015
To bolster clinical and commercial bulk drug production and fill/finish for gene therapies Read More »
Published May 12, 2015
Will collaborate to identify and validate tumor targets and corresponding TCRs in cancer Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
The new facility has already been deployed to manufacture a Humira biosimilar candidate in an upcoming Phase III trial Read More »
Published May 8, 2015
Additional 27,000 sq.-ft. will supply materials for clinical trials Read More »
Published May 7, 2015
Finalizes ISO 9001 and ISO 5001 Certification Read More »
Published April 30, 2015
Will be among the largest mammalian cell culture mfg. facilities using disposable bioreactors Read More »
Published April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Published April 17, 2015
Takeover expands Sartorius’ service portfolio Read More »
Published April 16, 2015
Reicin brings extensive research and leadership experience Read More »
Published April 10, 2015
Expands sterile bioprocessing portfolio Read More »
Published March 30, 2015
Merck Serono gains access to Intrexon's suite of technologies to engineer T-cells Read More »
Published March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Published March 23, 2015
To develop targeted anticancer therapeutics for as many as two undisclosed targets Read More »
Published March 16, 2015
Manufactures MVA EBOZ for Phase I trial Read More »
Published March 12, 2015
Will provide cGMP manufacture for clinical and commercial supply Read More »
Published March 9, 2015
Sandoz Zarxio approved for all indications on Filgrastim label Read More »
Published March 6, 2015
CoE in San Diego has 46,000 sq.-ft. of lab, office and sample storage space Read More »
Published March 2, 2015
Integrates continuous flow manufacturing technology Read More »
Published February 25, 2015
Opens newly expanded office Read More »
Published February 24, 2015
Will manufacture AB-022 for the treatment of cardiovascular diseases Read More »
Published February 23, 2015
Will develop TGF beta receptor kinase inhibitors Read More »
Published February 23, 2015
Expands immuno-oncology pipeline Read More »
Published February 23, 2015
Secures long-term lease in Bannockburn, IL Read More »
Published February 23, 2015
BBSRC competition invests £20M to bring innovative biotechnology projects to market Read More »
Published February 23, 2015
Expands filtration platform for life sciences and biopharma segments Read More »
Published February 19, 2015
Will manufacture GMP Cymerus MSC product for clinical and collaboration programs Read More »
Published February 19, 2015
Earns $20 million for the initiation of a key clinical trial Read More »
Published February 19, 2015
Will use LymPro test to evaluate lead drug candidate combination Read More »
Published February 17, 2015
To provide custom biomanufacturing for commercial production Read More »
Published February 12, 2015
U.S. Specialty Injectable segment drives growth in the quarter Read More »
Published February 10, 2015
Adds 11,000-sq.-ft. with dedicated space for ATF System Read More »
Published February 10, 2015
Aims to strengthen Pichia pastoris protein production Read More »
Published February 6, 2015
To generate bispecific molecules against multiple targets Read More »
Published February 2, 2015
To provide upstream process development from single-use biodevelopment center in France Read More »
Published February 2, 2015
Advances MS Research Read More »
Published January 30, 2015
To develop and commercialize JRC2-LAMP-vax to treat allergies Read More »
By Eric S. Langer and Jean-Claude Lupis, BioPlan Associates
Published January 29, 2015
Keep your eye on these trends in 2015. Read More »
Published January 27, 2015
Now provides comprehensive biotherapeutic protein analyses Read More »
Published January 22, 2015
Will research and develop approaches to CAR T cell therapy in cancer Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On